RITA Medical Systems
Fremont
About RITA Medical Systems
RITA Medical Systems develops, manufactures and markets innovative products for patients with solid cancerous or benign tumors. The proprietary RITA system uses radiofrequency energy to heat tissue to a high enough temperature to ablate it or cause cell death. While the Company's current focus is on liver cancer and metastatic bone cancer, the Company believes that its minimally invasive technology may in the future be applied to other types of tumors, including tumors of the lung, breast, uterus, prostate and kidney. The Company has received regulatory clearance in major markets worldwide, including the United States. In March 2000, RITA became the first radiofrequency ablation company to receive specific FDA clearance for unresectable liver lesions in addition to its previous general FDA clearance for the ablation of soft tissue. In October 2002, RITA again became the first company to receive specific FDA clearance, this time, for the palliation of pain associated with metastatic lesions involving bone. The Company has sold over 40,000 of its disposable devices throughout the world.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Total funding: $9.0M
- Funding stage: M&A
- Last round: Private Equity (Jan 2003)
- Website: ritamed.com
- Phone: +1 510-771-0400
Industries & Categories
Health Care, Information Technology, Manufacturing, Medical
Canonical: https://fsome.com/organization/rita-medical-systems-2439530 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.